Sartorius AG (SARTF) released earnings for its first half that Increases, from the same period last year
The company's bottom line came in at EUR81 million, or EUR2.44 per share. This compares with EUR60.9 million, or EUR2.15 per share, last year.
The company's revenue for the period rose 5.2% to EUR1.767 billion from EUR1.680 billion last year.
Sartorius AG earnings at a glance (GAAP) :
-Earnings: EUR81 Mln. vs. EUR60.9 Mln. last year.-EPS: EUR2.44 vs. EUR2.15 last year.-Revenue: EUR1.767 Bln vs. EUR1.680 Bln last year.
Michael Grosse, CEO of Sartorius AG, said: “We are satisfied with the business results for the first half of the year; the upward trend is continuing. We saw the expected growth momentum in the particularly high-margin business with consumables for pharma, which is of greatest relevance to us. I think we are well on track to achieve our ambitious targets for the year..."
Looking ahead, for the full year, the company has confirmed its outlook.
Sartorius AG still anticipates its underlying EBITDA margin to be in the range of around 29% to 30%, higher than the prior year’s 28%, with the margin for the Bioprocess Solutions Division rising to around 31% to 32% from last year’s 29.3%.
The Group continues to anticipate organic sales revenue growth to be around 6%, with around 7% in the Bioprocess Solutions Division. Due to the continued above-average volatility, the company currently projects a forecast range of about plus or minus two percentage points, respectively.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.